Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.
RISU
Randomized, Single-center, Open-label, Blinded Endpoint Assessment Study (Cross-over Study With 3 Study Products) on Bioavailability of Fatty Acids (Plasma Lipid Fractions) From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.
1 other identifier
interventional
19
1 country
1
Brief Summary
The purpose of the study is to compare the acute bioavailability of two different krill oil products called krill oil and krill meal in comparison to fish oil product.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 healthy
Started Feb 2014
Shorter than P25 for phase_2 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 13, 2014
CompletedFirst Posted
Study publicly available on registry
March 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedJune 4, 2014
June 1, 2014
3 months
March 13, 2014
June 3, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma phospholipids.
0-72 h
Secondary Outcomes (1)
Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma triglyceride.
0-72 h
Other Outcomes (1)
Mean proportions of fatty acids in plasma phospholipids and triglycerides.
0-72 h
Study Arms (3)
Krill oil
EXPERIMENTALThe interventions are administered in the randomized order.
Krill meal
EXPERIMENTALThe interventions are administered in the randomized order.
Fish oil
ACTIVE COMPARATORThe interventions are administered in the randomized order.
Interventions
Krill oil from Antarctic krill, per oral, capsule, targeted daily n-3 PUFA dose of 1 700 mg, single administration
Krill meal, granular meal from Antarctic krill, per oral, targeted daily n-3 PUFA dose of 1 700 mg, single administration
Fish oil, per oral, capsule, targeted daily n-3 PUFA dose of 1 700 mg, single administration
Eligibility Criteria
You may qualify if:
- Healthy female and male
- Age 18 - 65 years
- Body mass index 18.5 - 30
- Informed consent, signed
You may not qualify if:
- Medication potential to affect the bioavailability of fatty acids (e.g. lipid-lowering drugs)
- Familial hypercholesterolemia, marked combined hyperlipidemia, condition that would impair, fat absorption (e.g. chronic pancreatitis, pancreatic lipase deficiency syndrome)
- Any untreated medical condition affecting absorption of fat
- Type 1 and 2 diabetes
- Cancer or other malignant disease within past five years
- Periodical hormone replacement therapy
- High intake of oily fish (once a week or more) (i.e. salmon, herring, sardines, mackerel, vendace)
- Smoking
- Alcohol consumption \> 15 doses per week
- Females who are pregnant, breast-feeding or intend to become pregnant
- Hypersensitivity to any of the components of the test product
- Regular use of n-3 supplements 4 weeks before randomization
- Lack of suitability for participation in the trial, for any medical reason, as judged by the principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Olympic Seafood ASlead
- Oy Foodfiles Ltdcollaborator
Study Sites (1)
Oy Foodfiles Ltd, memeber of Foodfiles group
Kuopio, 70210, Finland
Related Publications (1)
Kohler A, Sarkkinen E, Tapola N, Niskanen T, Bruheim I. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial. Lipids Health Dis. 2015 Mar 15;14:19. doi: 10.1186/s12944-015-0015-4.
PMID: 25884846DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Essi S Sarkkinen, Ph.D
Oy Foodfiles Ltd, member of Foodfiles group
- PRINCIPAL INVESTIGATOR
Sakari A Nieminen, MD
Oy Foodfiles Ltd, memeber of Foodfiles group
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2014
First Posted
March 17, 2014
Study Start
February 1, 2014
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
June 4, 2014
Record last verified: 2014-06